Drug intelligence / Profile preview

ciprofloxacin + zinc sulfate

Development stage
Unknown
Lead developer
Bennet Pharmaceuticals
Modality
Small Molecules
Administration
Ophthalmic, Otic
01

Overview

BENOCIP-Z is a fixed-dose combination ophthalmic and otic solution developed by Bennet Pharmaceuticals. It contains ciprofloxacin, a second-generation fluoroquinolone antibiotic, and zinc sulfate, a topical astringent. Ciprofloxacin provides broad-spectrum antibacterial activity by inhibiting bacterial DNA gyrase (topoisomerase II) and topoisomerase IV, which are essential enzymes for DNA replication, transcription, and repair. Zinc sulfate acts as a mild astringent and antiseptic, helping to reduce ocular or aural discharge and inflammation by precipitating surface proteins. This combination is primarily indicated for the treatment of superficial bacterial infections of the eye, such as conjunctivitis and corneal ulcers, as well as inflammatory conditions of the external ear canal associated with bacterial pathogens.

Brand names
BENOCIP-Z
Other names
Ciprofloxacin and Zinc Sulfate Eye/Ear Drops
02

Targets

TOP2 (DNA topoisomerase 2)DNA gyraseTopo IV (Bacterial Topoisomerase IV)

Beyond the preview

Go deeper on ciprofloxacin + zinc sulfate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ciprofloxacin + zinc sulfate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call